ClinicalTrialsFinder

Refractory Membranous Nephropathy Clinical Trials in Xi'an, China

1 recruitingXi'an, China, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy

Refractory Membranous Nephropathy
The First Affiliated Hospital of Air Force Medicial University5 enrolled1 locationNCT07266181